12:00 AM
 | 
Mar 26, 2012
 |  BC Week In Review  |  Company News  |  Deals

Anaphore, RuiYi Biotechnology Inc. deal

Anaphore acquired RuiYi in a stock deal. Details were not disclosed. RuiYi discovers and develops biologics targeting GPCRs. RuiYi's co-founder...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >